Habitat fragmentation and anthropogenic factors affect wildcat Felis silvestris silvestris occupancy and detectability on Mt Etna

Knowledge of patterns of occupancy is crucial for planning sound biological management and for identifying areas which require paramount conservation attention. The European wildcat Felis silvestris is an elusive carnivore and is classified as ‘least concern’ on the IUCN red list, but with a decreasing population trend in some areas. Sicily hosts a peculiar wildcat population, which deserves conservation and management actions, due to its isolation from the mainland. Patterns of occupancy for wildcats are unknown in Italy, and especially in Sicily. We aimed to identify which ecological drivers determined wildcat occurrence on Mt Etna and to provide conservation actions to promote the wildcats’ long-term survival in this peculiar environment. The genetic identity of the wildcat population was confirmed through a scat-collection which detected 22 different wildcat individuals. We analysed wildcat detections collected by 91 cameras using an occupancy frame work to assess which covariates influenced the detection (p) and the occupancy (ψ) estimates. We recorded 70 detections of the target species from 38 cameras within 3377 trap-days. Wildcat detection was positively influenced by the distance to the major paved roads and negatively affected by the presence of humans. Wildcat occupancy was positively associated with mixed forest and negatively influenced by pine forest, fragmentation of mixed forest and altitude. A spatially explicit predicted occupancy map, validated using an independent dataset of wildcat presence records, showed that higher occupancy estimates were scattered, mainly located on the north face and at lower altitude. Habitat fragmentation has been claimed as a significant threat for the wildcat and this is the first study that has ascertained this as a limiting factor for wildcat occurrence. Conservation actions should promote interconnectivity between areas with high predicted wildcat occupancy while minimising the loss of habitat

Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients

Background: Early pathogenesis of diabetic cardiomyopathy (DMCM) may involve lipotoxicity of cardiomyocytes in the context of hyperglycemia. There are many preclinical studies of DMCM pathogenesis, but the human evidence is still poorly understood. Objectives: By using a nondiabetic mellitus (non-DM) heart transplanted (HTX) in diabetes mellitus (DM) recipients, this study conducted a serial study of human heart transplant recipients evaluating cardiac effects of diabetic milieu (hyperglycemia and insulin resistance) on lipotoxic-mediated injury. We evaluated cardiomyocyte morpho-pathology by seriated biopsies of healthy implanted hearts in DM recipients during 12-month follow-up from HTX. Because metformin reduces ectopic lipid accumulation, we evaluated the effects of the drug in a nonrandomized subgroup. Methods: The DMCM-AHEAD (Diabetes and Lipid Accumulation and Heart Transplant) prospective ongoing study (NCT03546062) evaluated 158 first HTX recipients (82 non-DM, 76 DM of whom 35 [46%] were receiving metformin). HTX recipients were undergoing clinical standard evaluation (metabolic status, echocardiography, coronary computed tomography angiography, and endomyocardial biopsies). Biopsies evaluated immune response, Oil Red-O staining, ceramide, and triacylglycerol levels. Lipotoxic factors and insulin resistance were evaluated by reverse transcriptase–polymerase chain reaction. Results: There was a significant early and progressive cardiomyocyte lipid accumulation in DM but not in non-DM recipients (p = 0.019). In the subgroup receiving metformin, independently from immunosuppressive therapy that was similar among groups, lipid accumulation was reduced in comparison with DM recipients not receiving the drug (hazard ratio: 6.597; 95% confidence interval: 2.516 to 17.296; p < 0.001). Accordingly, lipotoxic factors were increased in DM versus non-DM recipients, and, relevantly, metformin use was associated with fewer lipotoxic factors. Conclusions: Early pathogenesis of human DMCM started with cardiomyocyte lipid accumulation following HTX in DM recipients. Metformin use was associated with reduced lipid accumulation independently of immunosuppressive therapy. This may constitute a novel target for therapy of DMCM

Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients

Background: Early pathogenesis of diabetic cardiomyopathy (DMCM) may involve lipotoxicity of cardiomyocytes in the context of hyperglycemia. There are many preclinical studies of DMCM pathogenesis, but the human evidence is still poorly understood. Objectives: By using a nondiabetic mellitus (non-DM) heart transplanted (HTX) in diabetes mellitus (DM) recipients, this study conducted a serial study of human heart transplant recipients evaluating cardiac effects of diabetic milieu (hyperglycemia and insulin resistance) on lipotoxic-mediated injury. We evaluated cardiomyocyte morpho-pathology by seriated biopsies of healthy implanted hearts in DM recipients during 12-month follow-up from HTX. Because metformin reduces ectopic lipid accumulation, we evaluated the effects of the drug in a nonrandomized subgroup. Methods: The DMCM-AHEAD (Diabetes and Lipid Accumulation and Heart Transplant) prospective ongoing study (NCT03546062) evaluated 158 first HTX recipients (82 non-DM, 76 DM of whom 35 [46%] were receiving metformin). HTX recipients were undergoing clinical standard evaluation (metabolic status, echocardiography, coronary computed tomography angiography, and endomyocardial biopsies). Biopsies evaluated immune response, Oil Red-O staining, ceramide, and triacylglycerol levels. Lipotoxic factors and insulin resistance were evaluated by reverse transcriptase–polymerase chain reaction. Results: There was a significant early and progressive cardiomyocyte lipid accumulation in DM but not in non-DM recipients (p = 0.019). In the subgroup receiving metformin, independently from immunosuppressive therapy that was similar among groups, lipid accumulation was reduced in comparison with DM recipients not receiving the drug (hazard ratio: 6.597; 95% confidence interval: 2.516 to 17.296; p < 0.001). Accordingly, lipotoxic factors were increased in DM versus non-DM recipients, and, relevantly, metformin use was associated with fewer lipotoxic factors. Conclusions: Early pathogenesis of human DMCM started with cardiomyocyte lipid accumulation following HTX in DM recipients. Metformin use was associated with reduced lipid accumulation independently of immunosuppressive therapy. This may constitute a novel target for therapy of DMCM

Differential Histopathological and Behavioral Outcomes Eight Weeks after Rat Spinal Cord Injury by Contusion, Dislocation, and Distraction Mechanisms

The objective of this study was to compare the long-term histological and behavioral outcomes after spinal cord injury (SCI) induced by one of three distinct biomechanical mechanisms: dislocation, contusion, and distraction. Thirty male Sprague-Dawley rats were randomized to incur a traumatic cervical SCI by one of these three clinically relevant mechanisms. The injured cervical spines were surgically stabilized, and motor function was assessed for the following 8 weeks. The spinal cords were then harvested for histologic analysis. Quantification of white matter sparing using Luxol fast blue staining revealed that dislocation injury caused the greatest overall loss of white matter, both laterally and along the rostrocaudal axis of the injured cord. Distraction caused enlarged extracellular spaces and structural alteration in the white matter but spared the most myelinated axons overall. Contusion caused the most severe loss of myelinated axons in the dorsal white matter. Immunohistochemistry for the neuronal marker NeuN combined with Fluoro Nissl revealed that the dislocation mechanism resulted in the greatest neuronal cell losses in both the ventral and dorsal horns. After the distraction injury mechanism, animals displayed no recovery of grip strength over time, in contrast to the animals subjected to contusion or dislocation injuries. After the dislocation injury mechanism, animals displayed no improvement in the grooming test, in contrast to the animals subjected to contusion or distraction injuries. These data indicate that different SCI mechanisms result in distinct patterns of histopathology and behavioral recovery. Understanding this heterogeneity may be important for the future development of therapeutic interventions that target specific neuropathology after SCI

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study

In this prospective observational study, data were collected from 34 rheumatology clinics in Italy in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) who started golimumab (GLM) as a second anti-TNFα drug. The primary objective was to evaluate the effectiveness of GLM after 6 months. Changes in quality of life using the EQ-5D-5L were also assessed. A total of 194 patients aged 53.2 ± 12 years started GLM as a second anti-TNF drug: 39 (20.1%) with RA, 91 (46.9%) with PsA and 64 (32.9%) with axSpA. After 6 months of GLM treatment, 68% of RA patients achieved low disease activity (LDA; DAS28-CRP ≤ 3.2), 31.9% of PsA patients achieved minimal disease activity and 32.5% of axSpA patients achieved LDA (ASDAS-CRP &lt; 2.1). Good/moderate EULAR response was achieved in 61.9% and 73.8% of patients with RA and PsA, respectively, and 16% of axSpA patients achieved a 50% improvement in BASDAI. Across all indications, improvements in disease activity measures and EQ-5D-5L domains were observed over 6 months. The main reasons for GLM interruption were lack/loss of efficacy (7.2%) or adverse events (2%). This study confirms the effectiveness of GLM as a second-line anti-TNF for the treatment of RA, PsA and axSpA in a real-world setting in Italy

Obsolescenza dell’umano. Günther Anders e il contemporaneo

Il pensiero e la produzione teoretica di uno dei più grandi filosofi del Novecento, Günther Anders, la cui riflessione si rivela sempre più decisiva per la comprensione della complessa fenomenologia del contemporaneo, sono il cuore dei saggi contenuti in questo libro. Essi indagano le originali idee di Anders spaziando dalle questioni politiche agli interrogativi etici che animarono il suo attivismo critico, attraversando il suo originale approccio estetico e il suo apporto nell’ambito della critica letteraria. Un pensiero originale che viene così fruttuosamente messo a confronto con quello di molti tra i più importanti intellettuali coevi, come Arendt, Adorno, Benjamin, Heidegger, Freud, Lacan, Levi, Montale, Morselli, Pasolini, Eco e altri, con l’auspicio di segnare un rilevante progresso conoscitivo e critico nel contesto della letteratura e degli studi andersiani in Italia. Il volume raccoglie contributi di Micaela LATINI, Natascia MATTUCCI, Maria Pia PATERNÓ, Francesca R. RECCHIA LUCIANI, Andrea RONDINI, Antonio TRICOMI

Genere e religioni. Un dialogo interdisciplinare

Il volume \ue8 il risultato di due giornate seminariali organizzate nel 2017 e 2018 presso l\u2019Universit\ue0 degli Studi di Macerata che hanno messo a tema le differenze di genere e di religioni, attraverso uno sguardo multidisciplinare e transdisciplinare. I diversi contributi spaziano dalla filosofia alla medicina, dall\u2019antropologia alla politica, dalla storia alla sociologia e alla teologia, in un intreccio di prospettive accomunate da un interesse di ricerca che si addensa attorno al genere come domanda posta alle mentalit\ue0 e tradizioni religiose. Contributi di Francesca Bartolacci, Edoardo Bressan, Carla Canullo, Carla Carotenuto, Antonio Chiaese, Ines Corti, Martina Crescenti, Isabella Crespi, Elisabetta Croci Angelini, Maria Luisa Dupuis, Simona Epasto, Claudio Giovannini, Roberto Lambertini, Cinzia La Rocca, Walter Malorni, Natascia Mattucci, Serena Noceti, Maria Teresa Pagano, Donatella Pagliacci, Sabina Pavone, Amanda Rosini, Mina Sedhev, Daniela Verducci, Maria Letizia Zanier